{"id":22419,"date":"2025-10-13T12:30:07","date_gmt":"2025-10-13T12:30:07","guid":{"rendered":"https:\/\/itbusinesstoday.com\/?p=22419"},"modified":"2025-10-13T13:56:41","modified_gmt":"2025-10-13T13:56:41","slug":"novo-nordisk-acquires-akero-therapeutics-for-up-to-us-5-2-billion-implications-for-japans-biotech-and-tech-industries","status":"publish","type":"post","link":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/novo-nordisk-acquires-akero-therapeutics-for-up-to-us-5-2-billion-implications-for-japans-biotech-and-tech-industries\/","title":{"rendered":"\u30ce\u30dc \u30ce\u30eb\u30c7\u30a3\u30b9\u30af\u304c\u30a2\u30b1\u30ed \u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u3092\u6700\u592752\u5104\u7c73\u30c9\u30eb\u3067\u8cb7\u53ce\uff1a\u65e5\u672c\u306e\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u3068\u30cf\u30a4\u30c6\u30af\u7523\u696d\u3078\u306e\u5f71\u97ff"},"content":{"rendered":"

In October 2025, Novo Nordisk, a Danish pharma company, announced it will buy Akero Therapeutics, a US biotech firm, for as much as US$ 5.2 billion. This deal boosts Novo Nordisk’s options for treating metabolic diseases, especially non-alcoholic steatohepatitis (NASH). NASH is a liver issue often linked to obesity and diabetes. Novo Nordisk is serious about expanding in metabolic diseases. The acquisition helps with its work in treating obesity and diabetes.<\/p>

\u8cb7\u53ce\u306e\u5185\u5bb9<\/strong><\/p>

Novo Nordisk will buy Akero shares for US$ 54 each. This totals about US$ 4.7 billion upfront. It’s a 16.2% premium over Akero’s recent closing price. You could earn an extra US$ 6 per share if Akero’s main drug, Efruxifermin, gets full U.S. approval by June 2031. Efruxifermin is in late-stage trials for treating NASH. Novo Nordisk will take out a loan to fund the acquisition. The deal should close by the end of 2025.<\/p>

Impact on Japan’s Biotech and Tech Industries<\/strong><\/p>

The deal focuses on pharmaceuticals. However, it also impacts Japan’s biotech and tech industries. Japan is gearing up its biotech game right now. The Shonan iPark-LabCentral partnership links Asian biotech startups to the global market. Novo Nordisk<\/a>‘s move shows the strong need for metabolic disease treatments. This might lead Japanese biotech firms to change their R&D to match global trends.<\/p>

AI\u3084\u30c7\u30fc\u30bf\u5206\u6790\u304c\u5275\u85ac\u3084\u533b\u85ac\u54c1\u958b\u767a\u306b\u5e83\u304f\u6d3b\u7528\u3055\u308c\u308b\u3088\u3046\u306b\u306a\u308a\u307e\u3057\u305f\u3002AI\u3084\u30c7\u30fc\u30bf\u5206\u6790\u306b\u6ce8\u529b\u3059\u308b\u65e5\u672c\u306e\u30cf\u30a4\u30c6\u30af\u4f01\u696d\u306f\u3001\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u3068\u63d0\u643a\u3059\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3059\u3002\u3053\u306e\u63d0\u643a\u306f\u7814\u7a76\u3092\u5f37\u5316\u3059\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3059\u3002\u307e\u305f\u3001\u81e8\u5e8a\u8a66\u9a13\u3092\u7c21\u7d20\u5316\u3057\u3001\u60a3\u8005\u306e\u8ee2\u5e30\u306e\u6539\u5584\u306b\u3064\u306a\u304c\u308a\u307e\u3059\u3002<\/p>

\u3053\u3061\u3089\u3082\u304a\u8aad\u307f\u304f\u3060\u3055\u3044\uff1a \u82f1\u56fd\u3068\u65e5\u672c\u304c\u6226\u7565\u7684\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u63d0\u643a\u3092\u7d50\u3073\u3001\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u3092\u63a8\u9032<\/a><\/strong><\/h3>

\u30b0\u30ed\u30fc\u30d0\u30eb\u30fb\u30d3\u30b8\u30cd\u30b9\u3078\u306e\u5e83\u7bc4\u306a\u5f71\u97ff<\/strong><\/p>

\u30ce\u30dc \u30ce\u30eb\u30c7\u30a3\u30b9\u30af Akero Therapeutics<\/a>.\u3053\u308c\u306f\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u696d\u754c\u306e\u50be\u5411\u3092\u793a\u3057\u3066\u3044\u307e\u3059\u3002\u5404\u793e\u306f\u30dd\u30fc\u30c8\u30d5\u30a9\u30ea\u30aa\u3092\u5f37\u5316\u3057\u3001\u65b0\u305f\u306a\u6cbb\u7642\u5206\u91ce\u3092\u958b\u62d3\u3059\u308b\u305f\u3081\u306b\u5408\u4f75\u3057\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u50be\u5411\u306f\u3001\u4ed6\u306e\u88fd\u85ac\u4f1a\u793e\u3084\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u306b\u3082\u540c\u69d8\u306e\u53d6\u5f15\u3092\u63a8\u9032\u3055\u305b\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002\u3053\u308c\u306b\u3088\u308a\u3001\u6280\u8853\u9769\u65b0\u304c\u4fc3\u9032\u3055\u308c\u3001\u65b0\u305f\u306a\u6cbb\u7642\u6cd5\u306e\u5275\u51fa\u304c\u52a0\u901f\u3059\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002<\/p>

AI\u3001\u30c7\u30fc\u30bf\u5206\u6790\u3001\u30c7\u30b8\u30bf\u30eb\u30d8\u30eb\u30b9\u306e\u30c6\u30c3\u30af\u30d3\u30b8\u30cd\u30b9\u306f\u3001\u4ee3\u8b1d\u6027\u75be\u60a3\u3078\u306e\u6ce8\u76ee\u306e\u9ad8\u307e\u308a\u304b\u3089\u5229\u76ca\u3092\u5f97\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3059\u3002\u3053\u306e\u30c8\u30ec\u30f3\u30c9\u306f\u3001\u30b3\u30e9\u30dc\u30ec\u30fc\u30b7\u30e7\u30f3\u3068\u65b0\u3057\u3044\u30a2\u30a4\u30c7\u30a2\u306e\u30c1\u30e3\u30f3\u30b9\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002\u5275\u85ac\u3001\u81e8\u5e8a\u8a66\u9a13\u3001\u60a3\u8005\u30b1\u30a2\u306e\u5206\u91ce\u3067\u6280\u8853\u306b\u7cbe\u901a\u3057\u305f\u4f01\u696d\u306f\u3001\u4eca\u65e5\u3001\u6210\u529f\u3092\u53ce\u3081\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3059\u3002<\/p>

\u7d50\u8ad6<\/strong><\/p>

Novo Nordisk’s buy of Akero Therapeutics is a smart step into metabolic diseases. It’s a development that could have a ripple effect on the biotech and tech sectors. For Japan, it’s crucial to align its research and development with global trends. This deal also underscores the need for biotech and tech companies to team up. Partnering businesses will manage the global healthcare market more effectively.<\/p>","protected":false},"excerpt":{"rendered":"

In October 2025, Novo Nordisk, a Danish pharma company, announced it will buy Akero Therapeutics, a US biotech firm, for as much as US$ 5.2 billion. This deal boosts Novo Nordisk’s options for treating metabolic diseases, especially non-alcoholic steatohepatitis (NASH). NASH is a liver issue often linked to obesity and diabetes. Novo Nordisk is serious about expanding in metabolic diseases. The acquisition helps with its work in treating obesity and diabetes.Details of the AcquisitionNovo Nordisk will buy Akero shares for US$ 54 each. This totals about US$ 4.7 billion upfront. It’s a 16.2% premium over Akero’s recent closing price. You could earn an extra US$ 6 per share if Akero’s […]<\/p>\n","protected":false},"author":7,"featured_media":22413,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"wprm-recipe-roundup-name":"","wprm-recipe-roundup-description":"","postBodyCss":"","postBodyMargin":[],"postBodyPadding":[],"postBodyBackground":{"backgroundType":"classic","gradient":""},"footnotes":""},"categories":[208,181,89,211,237,8098,206],"tags":[8480,150,105,8481,106,8479,1225],"ppma_author":[572],"class_list":["post-22419","post","type-post","status-publish","format-standard","has-post-thumbnail","category-apac","category-biotech","category-health-tech","category-japan","category-news","category-news-articles","category-regional","tag-akero-therapeutics","tag-biotech","tag-itbusinesstoday","tag-metabolic-diseases","tag-news","tag-novo-nordisk","tag-pharmaceuticals"],"yoast_head":"\nNovo Nordisk Acquires Akero for $5.2B, Impacting Japan<\/title>\n<meta name=\"description\" content=\"Novo Nordisk to acquire Akero Therapeutics for up to $5.2B, enhancing its metabolic disease treatments, including NASH, obesity, and diabetes.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/novo-nordisk-acquires-akero-therapeutics-for-up-to-us-5-2-billion-implications-for-japans-biotech-and-tech-industries\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Novo Nordisk Acquires Akero for $5.2B, Impacting Japan\" \/>\n<meta property=\"og:description\" content=\"Novo Nordisk to acquire Akero Therapeutics for up to $5.2B, enhancing its metabolic disease treatments, including NASH, obesity, and diabetes.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/novo-nordisk-acquires-akero-therapeutics-for-up-to-us-5-2-billion-implications-for-japans-biotech-and-tech-industries\/\" \/>\n<meta property=\"og:site_name\" content=\"itbusinesstoday\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-13T12:30:07+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-13T13:56:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/10\/Novo-Nordisk-to-acquire-US-biotech-company-Akero-for-up-to-_5.2-billion.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"ITBT StaffWriter\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"ITBT StaffWriter\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"3\u5206\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u30ce\u30dc \u30ce\u30eb\u30c7\u30a3\u30b9\u30af\u304c\u30a2\u30b1\u30ed\u3092$5.2B\u3067\u8cb7\u53ce\u3001\u65e5\u672c\u306b\u3082\u5f71\u97ff","description":"\u30ce\u30dc \u30ce\u30eb\u30c7\u30a3\u30b9\u30af\u304c\u30a2\u30b1\u30ed \u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u3092\u6700\u5927$5.2B\u3067\u8cb7\u53ce\u3057\u3001NASH\u3001\u80a5\u6e80\u3001\u7cd6\u5c3f\u75c5\u306a\u3069\u306e\u4ee3\u8b1d\u6027\u75be\u60a3\u6cbb\u7642\u85ac\u3092\u5f37\u5316\u3002.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/novo-nordisk-acquires-akero-therapeutics-for-up-to-us-5-2-billion-implications-for-japans-biotech-and-tech-industries\/","og_locale":"ja_JP","og_type":"article","og_title":"Novo Nordisk Acquires Akero for $5.2B, Impacting Japan","og_description":"Novo Nordisk to acquire Akero Therapeutics for up to $5.2B, enhancing its metabolic disease treatments, including NASH, obesity, and diabetes.","og_url":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/biotech\/novo-nordisk-acquires-akero-therapeutics-for-up-to-us-5-2-billion-implications-for-japans-biotech-and-tech-industries\/","og_site_name":"itbusinesstoday","article_published_time":"2025-10-13T12:30:07+00:00","article_modified_time":"2025-10-13T13:56:41+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/10\/Novo-Nordisk-to-acquire-US-biotech-company-Akero-for-up-to-_5.2-billion.webp","type":"image\/webp"}],"author":"ITBT StaffWriter","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"ITBT StaffWriter","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"3\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/novo-nordisk-acquires-akero-therapeutics-for-up-to-us-5-2-billion-implications-for-japans-biotech-and-tech-industries\/#article","isPartOf":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/novo-nordisk-acquires-akero-therapeutics-for-up-to-us-5-2-billion-implications-for-japans-biotech-and-tech-industries\/"},"author":{"name":"ITBT StaffWriter","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/94fb575e469aff25a4b938814d050f15"},"headline":"Novo Nordisk Acquires Akero Therapeutics for Up to US$ 5.2 Billion: Implications for Japan\u2019s Biotech and Tech Industries","datePublished":"2025-10-13T12:30:07+00:00","dateModified":"2025-10-13T13:56:41+00:00","mainEntityOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/novo-nordisk-acquires-akero-therapeutics-for-up-to-us-5-2-billion-implications-for-japans-biotech-and-tech-industries\/"},"wordCount":459,"publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/novo-nordisk-acquires-akero-therapeutics-for-up-to-us-5-2-billion-implications-for-japans-biotech-and-tech-industries\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/10\/Novo-Nordisk-to-acquire-US-biotech-company-Akero-for-up-to-_5.2-billion.webp","keywords":["Akero Therapeutics","Biotech","itbusinesstoday","metabolic diseases","News","Novo Nordisk","pharmaceuticals"],"articleSection":["APAC","Biotech","Health Tech","Japan","News","News Articles","Regional"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/novo-nordisk-acquires-akero-therapeutics-for-up-to-us-5-2-billion-implications-for-japans-biotech-and-tech-industries\/","url":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/novo-nordisk-acquires-akero-therapeutics-for-up-to-us-5-2-billion-implications-for-japans-biotech-and-tech-industries\/","name":"\u30ce\u30dc \u30ce\u30eb\u30c7\u30a3\u30b9\u30af\u304c\u30a2\u30b1\u30ed\u3092$5.2B\u3067\u8cb7\u53ce\u3001\u65e5\u672c\u306b\u3082\u5f71\u97ff","isPartOf":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website"},"primaryImageOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/novo-nordisk-acquires-akero-therapeutics-for-up-to-us-5-2-billion-implications-for-japans-biotech-and-tech-industries\/#primaryimage"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/novo-nordisk-acquires-akero-therapeutics-for-up-to-us-5-2-billion-implications-for-japans-biotech-and-tech-industries\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/10\/Novo-Nordisk-to-acquire-US-biotech-company-Akero-for-up-to-_5.2-billion.webp","datePublished":"2025-10-13T12:30:07+00:00","dateModified":"2025-10-13T13:56:41+00:00","description":"\u30ce\u30dc \u30ce\u30eb\u30c7\u30a3\u30b9\u30af\u304c\u30a2\u30b1\u30ed \u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u3092\u6700\u5927$5.2B\u3067\u8cb7\u53ce\u3057\u3001NASH\u3001\u80a5\u6e80\u3001\u7cd6\u5c3f\u75c5\u306a\u3069\u306e\u4ee3\u8b1d\u6027\u75be\u60a3\u6cbb\u7642\u85ac\u3092\u5f37\u5316\u3002.","breadcrumb":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/novo-nordisk-acquires-akero-therapeutics-for-up-to-us-5-2-billion-implications-for-japans-biotech-and-tech-industries\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/itbusinesstoday.com\/health-tech\/biotech\/novo-nordisk-acquires-akero-therapeutics-for-up-to-us-5-2-billion-implications-for-japans-biotech-and-tech-industries\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/novo-nordisk-acquires-akero-therapeutics-for-up-to-us-5-2-billion-implications-for-japans-biotech-and-tech-industries\/#primaryimage","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/10\/Novo-Nordisk-to-acquire-US-biotech-company-Akero-for-up-to-_5.2-billion.webp","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/10\/Novo-Nordisk-to-acquire-US-biotech-company-Akero-for-up-to-_5.2-billion.webp","width":1200,"height":800,"caption":"Novo Nordisk Acquires Akero Therapeutics for Up to US$ 5.2 Billion: Implications for Japan\u2019s Biotech and Tech Industries"},{"@type":"BreadcrumbList","@id":"https:\/\/itbusinesstoday.com\/health-tech\/biotech\/novo-nordisk-acquires-akero-therapeutics-for-up-to-us-5-2-billion-implications-for-japans-biotech-and-tech-industries\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/itbusinesstoday.com\/"},{"@type":"ListItem","position":2,"name":"Novo Nordisk Acquires Akero Therapeutics for Up to US$ 5.2 Billion: Implications for Japan\u2019s Biotech and Tech Industries"}]},{"@type":"WebSite","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","description":"","publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","width":663,"height":275,"caption":"itbusinesstoday"},"image":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/94fb575e469aff25a4b938814d050f15","name":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc","image":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png90b3cb23d1d9c08733d969d29ea2d30d","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","caption":"ITBT StaffWriter"},"description":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc\u306f\u3001IT Business Today\u306e\u793e\u5185\u5bc4\u7a3f\u8005\u3067\u3001\u30bf\u30a4\u30e0\u30ea\u30fc\u306a\u30cb\u30e5\u30fc\u30b9\u3068QuickBytes\u306e\u914d\u4fe1\u3092\u62c5\u5f53\u3057\u3066\u3044\u307e\u3059\u3002IT\u3001\u30cf\u30a4\u30c6\u30af\u3001\u4f01\u696d\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306e\u6700\u65b0\u52d5\u5411\u3092\u30ab\u30d0\u30fc\u3057\u3001\u7c21\u6f54\u3067\u30a4\u30f3\u30d1\u30af\u30c8\u306e\u3042\u308b\u6700\u65b0\u60c5\u5831\u3092\u8aad\u8005\u306b\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002","sameAs":["https:\/\/itbusinesstoday.com\/"],"url":"https:\/\/itbusinesstoday.com\/ja\/author\/itbt-staffwriter\/"}]}},"authors":[{"term_id":572,"user_id":7,"is_guest":0,"slug":"itbt-staffwriter","display_name":"ITBT StaffWriter","avatar_url":{"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","url2x":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png"},"author_category":"","first_name":"ITBT","last_name":"StaffWriter","user_url":"https:\/\/itbusinesstoday.com\/","job_title":"","description":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc\u306f\u3001IT Business Today\u306e\u793e\u5185\u5bc4\u7a3f\u8005\u3067\u3001\u30bf\u30a4\u30e0\u30ea\u30fc\u306a\u30cb\u30e5\u30fc\u30b9\u3068QuickBytes\u306e\u914d\u4fe1\u3092\u62c5\u5f53\u3057\u3066\u3044\u307e\u3059\u3002IT\u3001\u30cf\u30a4\u30c6\u30af\u3001\u4f01\u696d\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306e\u6700\u65b0\u52d5\u5411\u3092\u30ab\u30d0\u30fc\u3057\u3001\u7c21\u6f54\u3067\u30a4\u30f3\u30d1\u30af\u30c8\u306e\u3042\u308b\u6700\u65b0\u60c5\u5831\u3092\u8aad\u8005\u306b\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002"}],"_links":{"self":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/22419","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/comments?post=22419"}],"version-history":[{"count":1,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/22419\/revisions"}],"predecessor-version":[{"id":22420,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/22419\/revisions\/22420"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media\/22413"}],"wp:attachment":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media?parent=22419"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/categories?post=22419"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/tags?post=22419"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/ppma_author?post=22419"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}